{
  "id": 135799,
  "title": "Novo vs. Lilly: Q2's cardiometabolic grudge match",
  "url": "https://urgent.news/2026/08/04/novo-vs-lilly-q2s-cardiometabolic-grudge-match",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-04T15:00:54.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/novo-vs-lilly-q2s-cardiometabolic-grudge-match/"
  },
  "original_language": "en",
  "account": null,
  "summary": "For years, Novo Nordisk and Eli Lilly have dominated the conversation surrounding obesity medicines as the duopoly competes to lead the largest pharmaceutical category in history. While dozens of companies are chasing their frontrunner status ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Lilly climbs, Novo falls as obesity drug battle intensifies",
        "url": "https://urgent.news/2026/08/05/lilly-climbs-novo-falls-as-obesity-drug-battle-intensifies",
        "published": "2026-08-05T15:22:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}